ANI Pharmaceuticals Inc ANIP

Healthcare Biotechnology

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel, as well as its generics business with enhanced research and development capabilities. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The Company has a commercial portfolio of approximately 118 products with a variety of indications and a robust portfolio of pipeline products.

NDAQ:ANIP - Post by User

ANI Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

(303)
•••

Post by whytestockson Oct 11, 2024 1:45pm

30 Views

Post# 36262960

Overweight Recommendation Issued On ANIP By Piper Sandler

News; $ANIP Overweight Recommendation Issued On ANIP By Piper Sandler2024-10-11 06:15:05 ET Piper Sandler analyst issues OVERWEIGHT recommendation for ANIP on October 11, 2024 04:47AM ET. ANIP was trading at $55.1 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy rec...ANIP - Overweight Recommendation Issued On ANIP By Piper Sandler

<< Previous

Bullboard Posts

Next >>

What is the 'kiddie tax' when gifting stock?